@FierceBiotech: Life sciences VC firm launches 'crowdfunding' site for limited crowd. More | Follow @FierceBiotech
@JohnCFierce: Pentagon advisor pocketed biotech's cash while promoting its interests - via LATimes. Report | Follow @JohnCFierce
@RyanMFierce: Interesting 'Open Research Exchange' platform debuts for creating outcome measures from the crowd. Release | Follow @RyanMFierce
> Shares of Peregrine Pharmaceuticals ($PPHM) shot up 19% early today after the biotech reported that it had reached an agreement with the FDA on the design of a late-stage study of the cancer drug bavituximab. The primary focus is on overall survival compared to chemotherapy. Story
> AstraZeneca ($AZN) officials are reportedly looking closely at a biomedical park near Cambridge in the U.K. as a likely site for its planned $500 million R&D complex, a central feature in its restructuring. Story
> Over the weekend Lundbeck touted Phase III data for the depression drug Brintellix (vortioxetine) demonstrating improvements in patients' symptoms. Report
> The Boston Globe reports on the nanotech work being done by biotech entrepreneur Omid Farokhzad, a close associate of MIT's Robert Langer. Story
Medical Device News
@FierceMedDev: Shoe-mounted lever could power artificial heart pumps. More | Follow @FierceMedDev
@MarkHFierce: Check out FierceDrugDelivery's latest - a great look at some advances in nanotech drug delivery. Special report | Follow @MarkHFierce
@DamianFierce: PRA is lining up to go public, filing a confidential draft with the SEC. Article | Follow @DamianFierce
> FDA slaps deadly label on Abbott's glucose meter recall. News
> PIP attorneys plead for leniency in breast implant fraud trial. Report
> Medtronic wins CE mark for clot-removal tech. More
Pharma News
@FiercePharma: Biopharma's 20 highest-paid CEOs. Our latest special report on exec pay. Report | Follow @FiercePharma
@EricPFierce: AstraZeneca rides Crestor to top of cardio drug list. Special report | Follow @EricPFierce
> Women want Apotex to pay for unwanted pregnancies. Article
> Actavis nabs Warner Chilcott in a $8.5B stock swap. News
> JVs like Pfizer, Hisun hookup provide Chinese companies shot at Western markets. Report
CRO News
> Nordion inks CMO deal with Navidea. Report
> After successful IPO, Quintiles plots 400 job cuts. Item
> PRA winds up for IPO. News
> Quintiles signs on to help Merck KGaA right the R&D ship. More
> PPD's BioDuro opens Shanghai discovery lab. Story
>WuXi's revenue jumps 11.7% in strong Q1. Article
Biotech IT News
> Drugmaker UCB taps IBM for digital medicine effort. Article
> InSilico Genomics grabs $1.5M for fledgling bioinformatics biz. Report
> Life sciences VC firm launches 'crowdfunding' site for limited crowd. Article
> Sanofi hunts for clinical trial recruits in growing social network. Story
> Merck targets docs with revamped U.K. website and healthcare apps. News
And Finally… Should we be wary of genomics' potential to treat cancer better? Blog